Legal & General Group’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-13,494
Closed -$21K 3592
2021
Q4
$21K Hold
13,494
﹤0.01% 3272
2021
Q3
$21K Hold
13,494
﹤0.01% 3265
2021
Q2
$35K Buy
+13,494
New +$25.1K ﹤0.01% 3080
2020
Q2
Sell
-18,674
Closed -$14K 3505
2020
Q1
$14K Sell
18,674
-4,348
-19% -$4.84K ﹤0.01% 3065
2019
Q4
$31K Sell
23,022
-57
-0.2% -$80 ﹤0.01% 3038
2019
Q3
$33K Buy
23,079
+2,280
+11% +$4.54K ﹤0.01% 2928
2019
Q2
$67K Buy
20,799
+7,366
+55% +$25.4K ﹤0.01% 2666
2019
Q1
$50K Hold
13,433
﹤0.01% 2713
2018
Q4
$29K Sell
13,433
-20,225
-60% -$50.2K ﹤0.01% 2926
2018
Q3
$91K Buy
33,658
+23,271
+224% +$82.2K ﹤0.01% 2542
2018
Q2
$44K Hold
10,387
﹤0.01% 2810
2018
Q1
$38K Hold
10,387
﹤0.01% 2883
2017
Q4
$39K Sell
10,387
-2,308
-18% -$9.24K ﹤0.01% 2953
2017
Q3
$55K Buy
12,695
+3,339
+36% +$13.8K ﹤0.01% 2885
2017
Q2
$39K Buy
9,356
+3,147
+51% +$12.3K ﹤0.01% 2981
2017
Q1
$23K Hold
6,209
﹤0.01% 3043
2016
Q4
$31K Buy
+6,209
New +$28.1K ﹤0.01% 3013

Legal & General Group's CSLT Position: Q1 2022 in Review

Legal & General Group sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 13,494 shares — an estimated $21K sold.

Legal & General Group first reported a position in CSLT in Q4 2016 and held it in 17 quarters. The position peaked at $91K in Q3 2018. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Legal & General Group reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Legal & General Group sold 13,494 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $21K.
  • Legal & General Group first reported a position in CASTLIGHT HEALTH, INC. in Q4 2016 and held it in 17 quarters.
  • Legal & General Group's CASTLIGHT HEALTH, INC. position peaked at $91K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on Legal & General Group's 13F filing for Q1 2022, filed 16 May 2022.